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OBJECTIVE: Veno-venous extracorporeal oxygenation for respiratory support has emerged as a rescue
alternative for patients with hypoxemia. However, in some patients with more severe lung injury,
extracorporeal support fails to restore arterial oxygenation. Based on four clinical vignettes, the aims of this
article were to describe the pathophysiology of this concerning problem and to discuss possibilities for
hypoxemia resolution.
METHODS: Considering the main reasons and rationale for hypoxemia during veno-venous extracorporeal
membrane oxygenation, some possible bedside solutions must be considered: 1) optimization of extracorporeal
membrane oxygenation blood flow; 2) identification of recirculation and cannula repositioning if necessary; 3)
optimization of residual lung function and consideration of blood transfusion; 4) diagnosis of oxygenator
dysfunction and consideration of its replacement; and finally 5) optimization of the ratio of extracorporeal
membrane oxygenation blood flow to cardiac output, based on the reduction of cardiac output.
CONCLUSION: Therefore, based on the pathophysiology of hypoxemia during veno-venous extracorporeal
oxygenation support, we propose a stepwise approach to help guide specific interventions.
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& INTRODUCTION
Veno-venous extracorporeal membrane oxygenation (VV-
ECMO) has been widely used to support patients with
severe acute respiratory distress syndrome (1-5). In some
patients, however, extracorporeal support fails to restore
arterial oxygenation (6-8). Knowledge of the multiple
mechanisms possibly underlying this failure to oxygenate
is essential for troubleshooting this concerning clinical
situation (6,9). In this manuscript, we use four clinical
vignettes to explore the potential mechanisms of severe
hypoxemia during VV-ECMO and to suggest possible
bedside solutions.
& CALCULATIONS
For the calculations, we used the standard formulas: (9,10)
N ECMO recirculation ratio (%) = (SatdO2 – ScvO2)6100 /
(SatrO2 – ScvO2);
N Pulmonary shunt (%) = (CcO2 – CvO2)6 100 / (CcO2 –
CaO2);
N CaO2 (mL O2 / 100 mL blood) = 1.36 6 Hb 6 Arterial
SatO2 + 0.00316PaO2;
N CvO2 (mL O2 / 100 mL blood) = 1.36 6 Hb 6 ScvO2 +
0.00316PvO2; and
N CcO2 (mL O2 / 100 mL blood) = 1.366Hb61 + 0.00316
(Ventilator FiO26 690).
SatdO2 – oxygen saturation at the drainage cannula;
ScvO2 – oxygen saturation at the superior vena cava; SatrO2
Copyright  2014 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2014(03)05
CLINICAL SCIENCE
173
– oxygen saturation at the return cannula; CxO2 – content of
oxygen in arterial (a), venous (v), or pulmonary capillary (c)
blood sample.
& CLINICAL VIGNETTES
Severe hypoxemia was diagnosed when PaO2 persisted at
less than 50 mm Hg in two arterial blood samples at least 60
minutes apart with ongoing VV-ECMO support. Blood
samples were collected while the patient slowly performed
three to four inspirations, to average the cyclic variations of
PaO2 during the respiratory cycle, which is common in
patients with severe ARDS (11). All ECMO-supported
patients were cannulated using a veno-venous configura-
tion. Patients 1, 3, and 4 were cannulated using the femoro–
jugular approach, in which a single, large, multiperforated
drainage cannula was inserted into the femoral vein and
was advanced to the cavo-atrial junction. The return
cannula was a single-stage catheter inserted into the right
internal jugular vein and advanced to the superior vena
cava. A femoro-femoral approach was used on patient 2, in
which both the drainage and return cannulae were inserted
through femoral veins. The first was positioned in the
superior cavo-atrial junction, and the second, in the inferior
vena cava.
The clinical characteristics of the patients are shown in
Table 1. In Table 2, the characteristics of the patients at the
time of the diagnosis of severe hypoxemia are described.
Cardiac output was estimated by transthoracic echocardio-
graphy using the velocity time integral technique. The ECMO
device consisted of a centrifugal magnetic pump with a
polymethylpentene oxygenation membrane (Rotaflow/
Jostra Quadrox - D, Maquet Cardiopulmonary AG,
Hirrlingen, Germany).
& DISCUSSION
Hypoxemia mechanisms during VV-ECMO support
Classically, during VV-ECMO, the extracorporeal trans-
membrane oxygen transfer depends primarily on ECMO
blood flow, and the transfer of carbon dioxide depends on
sweep gas flow (10,12). Arterial blood oxygenation results
from a more complex interplay among recirculation, ECMO
blood flow, oxygenator function, patient cardiac output
(CO), and pulmonary shunting (9).
For didactic reasons, the VV-ECMO support can be
modeled by two oxygenators in series: the extracorporeal
membrane and the native lungs (Figure 1 - Panel A) (9).
Through the first oxygenator (VV-ECMO apparatus), blood
drawn from the vena cava is pumped at a set flow rate,
leaving a fraction of the venous return, i.e., of the CO (13), to
proceed to the heart deoxygenated. Therefore, any elevation
of the CO, unaccompanied by equal elevations in the ECMO
blood flow, will result in a higher fraction of the CO
returning deoxygenated to the right heart and to the native
lungs (Figure 1 - Panel B). In this situation, the intuitive
reaction would be to increase the VV-ECMO blood flow to
improve oxygenation. This increase could, however, pre-
cipitate recirculation between the return and drainage
cannulae, mitigating any possible benefits (9). In addition,
high blood flows can cause hemolysis and collapse of the
inferior vena cava over the drainage cannula, suddenly
reducing blood flow and thus aggravating hypoxemia.
Some authors have recognized an ECMO blood flow to
cardiac output ratio greater than 0.6 as an index for ECMO
efficiency (12).
The second oxygenator in the model (native lungs,
Figure 1 – Panel A) will further improve blood oxygenation
according to its residual function, which is inversely
Table 1 - Characteristics of patients.
Patient 1 Patient 2 Patient 3 Patient 4
General characteristics
Age – yr 14 18 17 30
Sex F F M F
Weight – kg 48 48 84 60
SAPS 3 at ECMO beginning 105 89 74 95
Etiological diagnosis of ARDS SLE+alveolar hemorrhage Lobar pneumonia
+ cystic fibrosis
Aspiration
pneumonitis
Pneumocystosis
+ AIDS
ECMO retrieval By ambulance No retrieval By ambulance By ambulance
P/F ratio at ECMO beginning – mm Hg 36 43 47 55
PaCO2 at ECMO beginning – mm Hg 36 117 47 55
ECMO support characteristics
Configuration Veno-venous Veno-venous Veno-venous Veno-venous
Days on ECMO support 6 18 11 32
Anticoagulation No Yes Yes Yes
ECMO weaning and withdrawal Yes No Yes Yes
ICU support while on ECMO
Vasopressors Yes Yes Yes Yes
Inotropes Yes No Yes No
Renal replacement therapy Yes No Yes Yes
Mechanical ventilation Yes Yes Yes Yes
Other hypoxemia rescue therapy No Alveolar recruitment Nitric oxide Nitric oxide
90-day outcomes
Survival Yes No No No
Dialysis dependency No ---------- ---------- ----------
Oxygen dependency No ---------- ---------- ----------
ECMO - extracorporeal membrane oxygenation.
SLE - systemic lupus erythematosus.
AIDS - acquired immunodeficiency syndrome.
ICU - intensive care unit.
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proportional to the pulmonary shunt (9). The pulmonary shunt
can be modulated by decreasing the alveolar collapse, e.g., with
the use of higher levels of end-expiratory pressure. The
pulmonary shunt also depends on the CO, and it has been
shown that reducing CO in healthy lungs slightly improves
pulmonary shunting (14), an effect that is even more
pronounced in injured lungs during hypoxemic respiratory
failure (15). By the same token, the use of inotropic drugs can
worsen pulmonary shunting (16). Oxygenation of mixed
venous blood has been positively correlated with CO (17) and
is an important modulator of the pulmonary shunt (14,15,18). In
ICU patients, however, the response of the pulmonary shunt to
venous hypoxemia is erratic, depending on systemic factors
related to the underlying disease (19).
Blood recirculation from the return cannula to the
drainage cannula can reduce the efficacy of the ECMO
support because the membrane will oxygenate already
oxygenated blood (10), while the systemic venous blood will
return to the heart without proper oxygenation. Finally,
oxygenator dysfunction can also contribute to persistent
hypoxemia. The presence of blood clots or water drops
inside the membrane reduces the exchange surface and
consequently the oxygenator’s efficiency. This complication
can be diagnosed by the direct visualization of thrombi
inside the membrane or by the presence of low post-
oxygenation PO2 (Figure 2B) and high PCO2.
In summary, there are four main mechanisms of
hypoxemia during VV-ECMO: a high recirculation ratio, a
high pulmonary shunt, a low cardiac output to ECMO blood
flow ratio (,0.6), and oxygenator dysfunction. These
mechanisms can occur alone or, more frequently, in
combination. Figure 1 shows the equation for the prediction
of arterial oxygen saturation, using all of the concepts
discussed above (9).
Table 2 - Clinical characteristics at the time of severe hypoxemia diagnosis.
Patient 1 Patient 2 Patient 3 Patient 4
ECMO support
ECMO day of hypoxemia occurrence * 2 2 1 5
ECMO blood flow – mL/min 5080 6000 6500 5300
Sweep gas flow – L/min 2 5 10 7
FiO2 1 1 1 1
Drainage cannula diameter – French 20 22 21 22
Atrial cannula diameter – French 20 22 21 22
Drainage cannula SatO2 - % 58 85 61 64
Drainage cannula PO2 – mm Hg 30 46 32 35
Return cannula SatO2 - % 100 100 99 100
Return cannula PO2 – mm Hg 180 402 220 163
Blood flow/cardiac output ratio 0.57 0.61 0.56 0.50
Recirculation - % 26.3 62.5 7.3 20.0
Mechanical ventilation
Ventilatory mode PSV PCV PCV PCV
FiO2 0.3 0.6 1.0 0.6
PEEP – cm H2O 15 15 10 13
Plateau pressure – cm H2O 20 25 20 18
Tidal volume – mL 150 90 50 90
Respiratory rate – breaths/min 15 10 10 10
Patients characteristics
Arterial pH 7.421 7.435 7.500 7.370
PaCO2 – mm Hg 42 41 36 47
PvCO2 – mm Hg 52 51 61 59
PaO2 – mm Hg 46 45 45 37
PvO2 – mm Hg 23 29 35 30
Arterial Sat O2 - % 82 88 80 84
Venous Sat O2 - % 43 60 58 55
Hemoglobin – g/dL 7.4 7.5 8.2 8.0
Pulmonary shunt - % 36.6 44.9 62.9 47.8
Lactate – mmol/L 1.38 1.12 2.6 2.1
Lung injury score 3.75 3.50 4.00 3.75
Temperature - ˚C 37.2 38.0 39.0 37.6
Total SOFA 14 17 18 12
Hemodynamics
Cardiac output – L/min 8.9 9.8 11.5 10.6
Heart rate – beats/min 129 130 128 117
Mean arterial blood pressure – mm Hg 109 75 65 105
Central venous pressure – mm Hg 10 7 5 8
Inotropes in use None None None None
Vasopressors in use None Norepinephrine Norepinephrine None
Sedation and analgesia
Analgesia in use Fentanyl Fentanyl Fentanyl None
Sedation in use None Propofol Propofol None
RASS 0 -1 -5 0
*This was the first day of severe hypoxemia
RASS - Richmond agitation sedation scale.
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Practical approach for hypoxemia during VV-ECMO
support
The rationale for VV-ECMO support is to maintain
arterial oxygenation compatible with life and to prevent
further lung injury by allowing for the use of protective
ventilatory settings. Accordingly, a low driving pressure
(10 cm H2O), a high PEEP (10 - 15 cm H2O), a low
respiratory rate (10 breaths/minute), and a low FiO2 (0.3)
have been successfully combined with VV-ECMO support
Figure 1 - VV-ECMO–supported patient model. Panel A shows a regular patient, in whom the ECMO blood flow (3.5 L/min)/cardiac
output (5.0 L/min) ratio was equal to 0.7. In this condition, it is expected that only 1.5 L/min (30% of the venous return) will
pass through the vena cava without oxygenation. Panel B exemplifies a hyperdynamic patient, in whom the ECMO blood flow (3.5 L/
min)/cardiac output (10.0 L/min) ratio was equal to 0.35. In this example, 6.5 L/min (65% of the venous return) will pass through the
vena cava without oxygenation. In the former example, if the patient has a severe lung injury with a high pulmonary shunt, he or she
will most likely develop severe hypoxemia. SatdO2 – oxygen saturation at the drainage cannula. ScvO2 – oxygen saturation at the vena cava.
SatrO2 – oxygen saturation at the return cannula.
According to Mesai et al. (9):
Arterial SatO2~
Pulmonary oxygenation
Residual functionð Þ z
ECMO effective blood flow
Cardiac output
 
|SatrO2z
1{ECMO effective blood flow
Cardiac output
 
|ScvO2z 0:1|SatrO2ð Þ
ECMO effective blood flow=(1 – recirculation ratio)6ECMO blood flow.
Figure 2 - Panel A shows the systemic arterial content of oxygen as a function of ECMO blood flow, and Panel B shows the expected PO2
in the return cannula as a function of ECMO blood flow. Both panels were created based on a polymethylpentene oxygenator with
normal function. In this graph, the original data from the swine experimental study of Park et al. were used (10). The data used
presented a wide range of pre-membrane pH, drainage cannula SatO2, and drainage cannula PO2. The data were collected during a
baseline clinical situation, without organ dysfunctions and after 12 hours of peritonitis and severe lung injury induction.
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with good outcomes (2). To maintain this protective
ventilation, an arterial saturation $85% or a PaO2$50 mm
Hg has been considered sufficient while maintaining low
alveolar ventilation (8,20). However, certain patients with
refractory hypoxemia do not achieve this minimal safe
oxygenation under protective ventilation settings. For these
patients, we suggest a sequential approach (Figure 3),
aiming for an arterial SatO2$85% in patients with a normal
or near normal PaCO2.
The approach presented in Figure 3 is based on the
following ideas: 1) optimizing the ECMO blood flow to
cardiac output ratio (initially manipulating the ECMO blood
flow), 2) identifying recirculation and repositioning of the
cannulae accordingly, 3) optimizing residual lung function,
4) diagnosing oxygenator dysfunction and considering its
replacement, and 5) optimizing the ECMO blood flow to
cardiac output ratio based on the reduction in cardiac
output (avoiding fever or providing active patient cooling,
decreasing oxygen consumption if necessary with neuro-
muscular blockers, and possibly reducing cardiac output
with the use of beta-blockers after careful consideration of
the potential clinical deterioration due to cardiovascular
depression) (6,8). Blood transfusions to optimize the DO2
can be considered at any time.
Permissive hypoxemia is an option, according to the patient’s
clinical situation, when other interventions have failed. Severe
ARDS patients without VV-ECMO support develop long-term
neuropsychological impairment associated with hypoxemia in
the acute phase of the disease (21). However, in VV-ECMO–
supported severely injured patients, an arterial SatO2 as low as
70% has been allowed in awake and participative patients with
normal arterial PCO2 (7), with a high survival rate (76%) and
without significant long-term sequelae in health-related quality
of life (7,22). Maintaining a normal PCO2 seems to be
mandatory in permissive severe hypoxemia because the
association of low PO2 with high PCO2 can potentially cause
severe brain injury (23).
The clinical vignettes
Patient 1 – She was awake and collaborative, with a high
recirculation ratio and a low ECMO blood flow to cardiac
output. The ventilator FiO2 was 0.3. In this patient, the
ECMO blood flow was raised to 6000 mL/min when the
SpO2 reached 85%.
Patient 2 – This patient was cannulated with a femoro-
femoral approach, with a high recirculation ratio and an
adequate ECMO blood flow to cardiac output ratio. Due to
difficulty in repositioning the cannulae, we chose to perform
Figure 3 -A stepwise approach for severe hypoxemia etiology diagnosis and resolution during VV-ECMO respiratory support. Possible causes of
the persistent hypoxemia: 1. Blood flow/Cardiac output , 0.6. 2. Recirculation. 3. High pulmonary shunt. 4. Oxygenator dysfunction.
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alveolar recruitment. A slight improvement in oxygenation was
obtained, keeping the arterial SatO2 between 85 and 89%.
Patient 3 – The patient was febrile and hyperdynamic.
There was no recirculation, and the ECMO blood flow to
cardiac output was low (ratio = 0.56). This patient received
active interventions to control the fever, which slowly
improved the hypoxemia.
Patient 4 – This patient had a low ratio of ECMO blood
flow to cardiac output and a low recirculation ratio. The
ECMO blood flow was raised, thereby bringing the
hypoxemia to an acceptable level.
Severe hypoxemia can occur during VV-ECMO respira-
tory support, and it is crucial to understand the underlying
mechanisms. Knowledge of the pathophysiology of hypox-
emia is important to guide specific interventions. A
stepwise approach, as proposed here, can often be used to
address this concerning clinical situation. When other
alternatives have failed, permissive severe hypoxemia is
acceptable. In this group of patients, maintaining normo-
capnia is essential to attenuate the risk of associated
sequelae.
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